preeclampsia - Nursing Case Study
Pathophysiology
• Primary mechanism: Endothelial dysfunction - In preeclampsia, abnormal placentation leads to reduced blood flow to the placenta, causing the release of factors that damage maternal endothelial cells, resulting in hypertension and proteinuria.
• Secondary mechanism: Imbalance of angiogenic factors - An increase in anti-angiogenic factors, like sFlt-1, and a decrease in pro-angiogenic factors, like PlGF, disrupts blood vessel formation, exacerbating hypertension and contributing to organ damage.
• Key complication: Multisystem involvement - The endothelial damage and angiogenic imbalance can lead to complications like renal impairment, liver dysfunction, and cerebral edema, highlighting the importance of early detection and management to prevent severe outcomes.
Patient Profile
Demographics:
28-year-old female, office manager
History:
• Key past medical history: Gestational hypertension in a previous pregnancy
• Current medications: Prenatal vitamins, labetalol
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Persistent headache and visual disturbances
• Key symptoms: Swelling in hands and feet, upper abdominal pain, nausea
• Vital signs: Blood pressure 160/100 mmHg, heart rate 95 bpm, respiratory rate 20 breaths per minute, temperature 98.6°F, oxygen saturation 97%
Section 1
As the clinical team continues to monitor the patient, new diagnostic results reveal significant proteinuria, with a 24-hour urine collection showing 4.5 grams of protein, confirming the progression to preeclampsia with severe features. Laboratory tests also indicate elevated liver enzymes (AST 85 U/L and ALT 90 U/L), suggesting hepatic involvement, while platelet count remains on the lower boundary of normal at 135,000/mm³. These findings align with her symptoms of upper abdominal pain and nausea, pointing towards potential hepatic strain or early HELLP syndrome. The elevated blood pressure, persistent headaches, and visual disturbances further necessitate careful surveillance for potential neurological complications such as cerebral edema or eclampsia.
In response to these findings, the clinical team decides to initiate intravenous magnesium sulfate for seizure prophylaxis and adjusts the labetalol dosage to better control her blood pressure. Fluid management is approached cautiously to avoid exacerbating her edema and potential pulmonary complications. The patient is counseled regarding the seriousness of her condition, emphasizing the need for potential early delivery to mitigate risks to both her and the fetus. The obstetrics team is engaged to assess fetal well-being through continuous fetal monitoring and biophysical profiles, ensuring any signs of fetal distress are promptly addressed.
This comprehensive approach underscores the importance of interdisciplinary collaboration in managing preeclampsia with severe features. The integration of diagnostic data and clinical interventions aims to stabilize the patient's condition while preparing for possible escalation in care, such as expedited delivery if maternal or fetal status deteriorates. The team remains vigilant, recognizing that timely detection and management of new complications are crucial in improving outcomes for both the mother and her unborn child.
Section 2
New Complications
As the clinical team continues to manage the patient, her condition begins to show signs of further complication. Despite the initiation of magnesium sulfate for seizure prophylaxis, the patient experiences a generalized tonic-clonic seizure, indicating progression to eclampsia. This development prompts an urgent reassessment of her treatment plan. The seizure is swiftly managed with an additional bolus of magnesium sulfate and supportive care, but it underscores the need for heightened vigilance and potential escalation of care. Her blood pressure, which had been moderately controlled with the adjusted labetalol regimen, spikes to 180/110 mmHg post-seizure, necessitating the introduction of hydralazine for more aggressive blood pressure management.
Concurrently, the fetal monitoring reveals intermittent late decelerations, suggesting possible fetal distress. An immediate biophysical profile is conducted, indicating a score of 4 out of 10, which raises concerns about fetal well-being. The obstetrics team deliberates on the timing of delivery, weighing the risks of continued gestation against the potential benefits of allowing further fetal development. Given the new complications, a decision is made to expedite delivery via cesarean section to safeguard both maternal and fetal health. This decision is communicated clearly to the patient and her family, ensuring they understand the urgency and rationale behind the expedited delivery. The team prepares for the procedure, with neonatal specialists on standby to provide immediate care for the newborn, anticipating potential complications due to prematurity. This collaborative and proactive approach aims to optimize outcomes amidst the evolving clinical scenario.
Section 3
As the clinical team initiates preparations for the cesarean section, they undertake a comprehensive initial assessment of the patient to ensure readiness for surgery. The patient's vital signs are monitored closely; her blood pressure remains elevated at 175/105 mmHg despite the administration of hydralazine, and her heart rate is noted to be 110 beats per minute. Respiratory rate is at 22 breaths per minute, and oxygen saturation is stable at 96% on room air. A focused neurological assessment reveals that she is slightly disoriented and reports a persistent headache, which could be attributed to the elevated blood pressure or the magnesium sulfate administration, both of which require careful monitoring.
Laboratory results are reviewed urgently, revealing a concerning trend: her liver function tests show elevated levels of AST and ALT, indicative of hepatic stress, and her platelet count has dropped to 95,000/mm³, suggesting the development of HELLP syndrome. These findings necessitate a swift yet thorough evaluation of her coagulation profile to ensure safe surgical planning, as well as the potential need for platelet transfusion preoperatively. Additionally, her urine output is decreased, raising suspicions of potential renal involvement, which further complicates her clinical picture.
In response to these findings, the clinical team adjusts the treatment plan to stabilize the patient's status before proceeding to the operating room. Intravenous fluids are carefully managed to optimize intravascular volume without exacerbating hypertension or risking pulmonary edema. A multi-disciplinary team, including anesthesia, obstetrics, and neonatology, convenes to discuss the safest approach for both the mother and the baby. This collaborative effort underscores the complexity of managing preeclampsia and eclampsia, especially when accompanied by HELLP syndrome, as the team strives to balance the risks and benefits of immediate intervention while preparing for potential intraoperative and postoperative challenges.
Section 4
As the clinical team continues to monitor the patient closely, a sudden change in her status prompts immediate reevaluation of the treatment plan. The patient begins to exhibit increased confusion and irritability, suggesting potential neurological complications. Her blood pressure remains persistently high at 180/110 mmHg despite multiple doses of antihypertensives. The magnesium sulfate infusion, aimed at preventing seizures, is titrated to maintain therapeutic levels, but her reflexes are now brisk, indicating a possible escalation towards eclampsia.
Simultaneously, the patient's urine output has further decreased, now measuring less than 20 mL/hour, signaling worsening renal function. This oliguria, coupled with rising serum creatinine levels now at 1.8 mg/dL, confirms acute kidney injury likely secondary to severe preeclampsia. The team must balance fluid administration carefully to support renal perfusion while avoiding fluid overload, given the patient's hypertensive state and risk of pulmonary edema.
Considering these developments, the interdisciplinary team prioritizes rapid stabilization. An urgent discussion with anesthesia addresses the need for potential general anesthesia if neurological status continues to deteriorate. Neonatology is prepared for the potential challenges of delivering a preterm infant affected by maternal complications. The focus shifts to expediting the cesarean section while ensuring all safety protocols are in place to manage the patient's evolving condition, emphasizing the need for precise clinical judgment and collaboration.
Section 5
As the clinical situation progresses, the team receives new diagnostic results that shed light on the underlying complications. A head CT scan is performed to assess the patient's neurological status, revealing signs of cerebral edema, which explains her increasing confusion and irritability. This finding confirms the escalation towards eclampsia and necessitates further adjustments in her management plan. Concurrently, the patient's laboratory results show worsening thrombocytopenia, with platelet counts dropping to 80,000/microliter, raising concerns about the development of HELLP syndrome (Hemolysis, Elevated Liver enzymes, Low Platelet count). Liver function tests reveal elevated AST and ALT levels, now at 150 U/L and 170 U/L respectively, indicating hepatic involvement and increasing the risk of significant bleeding during delivery.
In response to these developments, the interdisciplinary team intensifies their focus on stabilizing the patient. The magnesium sulfate infusion is carefully adjusted to achieve optimal therapeutic levels, while the nursing team monitors her neurological status and reflexes vigilantly for any further deterioration. The obstetrics team collaborates closely with anesthesia to prepare for an expedited cesarean section, given the growing urgency to deliver the preterm infant and mitigate maternal risks. Neonatology prepares for potential neonatal resuscitation and management of complications arising from preterm birth. With close coordination and clear communication, the team ensures all safety protocols are ready for the cesarean section. Blood products are cross-matched and on standby in anticipation of possible hemorrhagic complications, reflecting the need for precise clinical judgment and proactive planning.